ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag child care academia drug development industry collaboration

Industry vs Academia
The Scientist Staff | Apr 15, 2001 | 10+ min read
To conduct this survey, The Scientist invited 1800 readers via E-mail to respond to a web-based survey form. There were a total of 220 responses from March 2 to 12, 2001, a response rate of 12.2%. Have you held research positions in both academia and industry? (Positions may include graduate research, industrial internships, or any other research positions - paid or unpaid - in both work environments).   Percent Count Answers 72.6% 159/219 Yes 27.4% 60/219 No
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017 | 10+ min read
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
Best Places to Work Academia, 2012
The Scientist | Aug 1, 2012 | 9 min read
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Minding the Drug Development Gap
Edward Spack | Nov 6, 2005 | 6 min read
Twenty-five years after the enactment of the Bayh-Dole Act, scientists and administrators in academia who are interested in moving bench discoveries to the clinic are learning what travelers in London's subway system already know: It's important to "mind the gap."
DNAX Immunologists Work To Balance Industry, Academia
Laurel Joyce | Nov 12, 1989 | 6 min read
The fence between industry and academia seems like a precarious place to sit. But a team of California scientists makes the balancing act look easy. Their perch on that fence has been the perfect place for cranking out highly cited research, including four “Hot Papers” identified by The Scientist in the past year (May I, 1989, page 12). The laboratories of immunologists Robert Coffman and Tim Mosmann are side by side on the secondfloor of DNAX Research Institute in Palo Alto. Se
Tag, You're It
Carina Storrs | Feb 1, 2014 | 7 min read
A guide to DNA-encoded libraries for drug discovery
When Big Pharma Courts Academia
Joseph Paone | Jan 20, 2002 | 6 min read
Norman Greenberg tests AstraZeneca compounds on mice he genetically engineered to develop prostate cancer. He supplies the animals and the system for verifying the effectiveness of chemotherapy treatments while the company provides the compounds and testing costs, and gives Greenberg ample opportunity to prove just how well his system works. Together, the scientist from Baylor College of Medicine in Houston and his corporate partner warily straddle the barrier between academia and industry, and
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Corporate Research: Best Labs Combine Virtues Of Both Academia And Industry
Franklin Hoke | May 30, 1993 | 9 min read
Commercial productivity is the payoff when firms provide scientists with a comfortably collegiate professional environment Recognizing the successful tradition of the university science environment, industry research directors are carrying over the academic spirit in their efforts toward building harmonious and productive labs. Their aim is to preserve the pursuit of pure discovery and the free exchange of ideas, while at the same time moving assertively toward the achievement of commer
Working in Drug Discovery Research
Jennifer Fisher Wilson | Mar 4, 2001 | 5 min read
Courtesy Eli Lilly and Co.Kevin Tichenor (left) and Chahrzad Montrose (right) dissolve compounds and place them in various plate formats required for biological screeing. Life science researchers may think that the most viable career opportunities lie in academia or other nonprofit settings. For scientists who are drawn to an intensive research environment, however, the pharmaceutical industry offers another option. While focused on high-quality research just like academia, the drug discovery i

Run a Search

ADVERTISEMENT